Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes

<p>Abstract</p> <p>Background</p> <p>Osteoprotegerin is a member of the tumor necrosis factor-related family and inhibits RANK stimulation of osteoclast formation as a soluble decoy receptor. The goal of this study was to determine the relationship of serum osteoprotege...

Full description

Bibliographic Details
Published in:	Cardiovascular Diabetology
Main Authors:	Aoki Atsushi, Murata Miho, Asano Tomoko, Ikoma Aki, Sasaki Masami, Saito Tomoyuki, Otani Taeko, Jinbo Sachimi, Ikeda Nahoko, Kawakami Masanobu, Ishikawa San-e
Format:	Article
Language:	English
Published:	BMC 2013-01-01
Subjects:	Osteoprotegerin Vascular calcification Atherosclerosis Type 2 diabetes mellitus
Online Access:	http://www.cardiab.com/content/12/1/11

Similar Items

The serum levels of FGF23, sclerostin, osteoprotegerin do not explain the inverse relationship between coronary calcifications and bone mineral density evaluated using computed tomography
by: Laurence Ferrières, et al.
Published: (2025-06-01)

Relationships between Osteopontin, Osteoprotegerin, and Other Extracellular Matrix Proteins in Calcifying Arteries
by: Aleksandra Kuzan, et al.
Published: (2024-04-01)

Arterial stiffness, vascular calcification and osteoporosis — common mechanisms of interaction (literature review)
by: O.I. Nishkumay, et al.
Published: (2022-06-01)

Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis
by: Marcela Ávila, et al.
Published: (2022-04-01)

Osteoprotegerin Gene Polymorphisms Are Associated with Subclinical Atherosclerosis in the Mexican Mestizo Population
by: Benny Giovanni Cazarín-Santos, et al.
Published: (2022-06-01)

Mechanism of Bushen Huoxue Recipe on Improving Arterial Calcification in Rats with Osteoporosis Based on OPG/RANKL Signaling Pathway
by: LIN Xiaorong, et al.
Published: (2022-08-01)

Serum Osteoprotegerin and Carotid Intima-Media Thickness Are Related to High Arterial Stiffness in Heart Failure with Reduced Ejection Fraction
by: Lajos Fehérvári, et al.
Published: (2021-04-01)

Osteoprotegerin mediates adipogenesis in obesity
by: Zipan Lyu, et al.
Published: (2024-08-01)

Osteoprotegerin is a new marker of cardiovascular diseases
by: A F Verbovoy, et al.
Published: (2017-04-01)

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis
by: Michalis Spartalis, et al.
Published: (2023-02-01)

Investigating the role of osteoprotegerin gene polymorphic variants in osteoporosis
by: Bulat I. Yalaev, et al.
Published: (2021-03-01)

Biomarkers of vascular calcification: their relationship with diseases of the cardiovascular system and their importance in clinical practice
by: N. A. Maslatsov, et al.
Published: (2021-06-01)

Osteoprotegerin, sclerostin, and osteocalcin serum levels in thyroid disorder patients
by: F. F. Rija, et al.
Published: (2021-10-01)

Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients
by: Changlei Guo, et al.
Published: (2013-01-01)

Serum level of osteoprotegerin in patients with Parkinson’s disease: a preliminary study
by: Marta Piaścik-Gromada, et al.
Published: (2024-03-01)

Osteoprotegerin gene polymorphisms in postmenopausal women with knee osteoarthritis
by: Grigorii A. Ignatenko, et al.
Published: (2024-06-01)

The Relationship of Osteoprotegerin with Cardiovascular Risk Factors in Women with and Without Polycystic Ovary Syndrome
by: Gültekin Adanaş Aydın, et al.
Published: (2020-06-01)

Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
by: Fatima U. Dzgoeva, et al.
Published: (2022-08-01)

The role of osteoprotegerin (OPG) in exercise-induced skeletal muscle adaptation
by: Owens Aaron, et al.
Published: (2024-12-01)

THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01)

Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
by: Stella Bernardi, et al.
Published: (2017-07-01)

The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms
by: Migacz Maciej, et al.
Published: (2020-05-01)

Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis
by: Jerzy Chudek, et al.
Published: (2025-01-01)

Cardiovascular Risk Assessement in Osteoporotic Patients Using Osteoprotegerin as a Reliable Predictive Biochemical Marker
by: Noora Wael Rasheed, et al.
Published: (2018-04-01)

Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly
by: Aleksandra Jawiarczyk-Przybyłowska, et al.
Published: (2022-04-01)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
by: Yen-Liang Chen, et al.
Published: (2023-10-01)

The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox
by: Flora Özkalaycı, et al.
Published: (2018-05-01)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
by: Guanghao Chi, et al.
Published: (2023-11-01)

Placenta-Derived Osteoprotegerin Is Required for Glucose Homeostasis in Gestational Diabetes Mellitus
by: Binbin Huang, et al.
Published: (2020-09-01)

Pathogenetic relationship between coronary heart disease and osteopenic syndrome
by: N. S. Mykhailovskaya, et al.
Published: (2015-02-01)

Serum osteoprotegerin and its gene polymorphisms in patients with Takayasu’s arteritis: a bicentric cross-sectional study
by: Camila da Silva Cendon Duran, et al.
Published: (2024-05-01)

Changes in the Structural and Functional State of Bone Tissue, the Level of Osteoprotegerin in Women with Ischemic Heart Disease in Postmenopause
by: O.I. Nishkumay
Published: (2013-08-01)

Osteoprotegerin in infection-induced acute inflammatory states in children
by: Aristeidis Giannakopoulos, et al.
Published: (2024-03-01)

The association of plasma osteoprotegerin levels and functional outcomes post endovascular thrombectomy in acute ischemic stroke patients: a retrospective observational study
by: Moo-Seok Park, et al.
Published: (2022-05-01)

Osteoprotegerin autoantibodies do not predict low bone mineral density in middle-aged women
by: Fariba Vaziri-Sani, et al.
Published: (2017-12-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
by: Chan Kai-Ming, et al.
Published: (2011-07-01)

Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
by: Filip Przerwa, et al.
Published: (2023-12-01)

Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis
by: Chia-Wen Lu, et al.
Published: (2021-07-01)

Perbedaan Kadar Osteoprotegerin Serum Penderita Diabetes Melitus Tipe 2 tanpa dan dengan Penyakit Jantung Koroner
by: Ratri Dwitiya Nestiti, et al.
Published: (2015-12-01)

Role of osteoprotegerin rs3102735 gene polymorphism in acute ischemic stroke patients
by: Dina Monir, et al.
Published: (2023-04-01)